Pharmacy
Home Pharmacy
Daily BCX7353 Cuts Rate of Hereditary Angioedema Attacks
Oral administration of BCX7353 at dose of ≥125 mg results in lower rate of attacks versus placebo
ACOG, Others Come Out Against Proposed Rule on Title-X
Organizations representing over 700,000 providers oppose efforts to limit Title-X program
WHO Targets for Chronic Hepatitis B Will Be Cost-Effective
Achieving WHO targets for diagnosis, treatment by 2030 will be cost-effective at $103 per QALY
Steroid Abuse Put 60-Year-Old Bodybuilder in the Hospital
Patient was eventually diagnosed with non-ischemic cardiomyopathy
Tools, Methods of RCTs Can Be Adapted to Real-World Settings
3 options described for applying approaches used in randomized controlled trials to real-world data
HerbList App Launched to Provide Information on Herbal Products
NIH app provides scientific, research-driven info on safety, side effects, herb-drug interactions
Escitalopram Cuts MACE Risk in Depressed Patients With ACS
Higher risk of major adverse cardiac events with concurrent depression after acute coronary syndrome
Guidelines for ART Updated for Those With or at Risk for HIV
ART recommended for almost all HIV-infected; should be initiated as soon as possible post diagnosis
Regulations Restrict Providers’ Ability to Offer Info on Abortions
And, HHS regulations mandate physical, financial separation between Title X activities, abortions
One-Third of Hep C Rx Receive Absolute Denial From Insurers
Both private and public insurers continue to deny coverage for drugs at high rates